000 | 01200 a2200349 4500 | ||
---|---|---|---|
005 | 20250517174835.0 | ||
264 | 0 | _c20190702 | |
008 | 201907s 0 0 eng d | ||
022 | _a1535-4970 | ||
024 | 7 |
_a10.1164/rccm.201709-1831LE _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLipson, David A | |
245 | 0 | 0 |
_aReply to Suissa and Ariel: The FULFIL Trial. _h[electronic resource] |
260 |
_bAmerican journal of respiratory and critical care medicine _c02 2018 |
||
300 |
_a542-543 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHypoglycemic Agents |
650 | 0 | 4 | _aPulmonary Disease, Chronic Obstructive |
700 | 1 | _aBarnacle, Helen | |
700 | 1 | _aBirk, Ruby | |
700 | 1 | _aBrealey, Noushin | |
700 | 1 | _aLocantore, Nicholas | |
700 | 1 | _aLomas, David A | |
700 | 1 | _aLudwig-Sengpiel, Andrea | |
700 | 1 | _aMohindra, Rajat | |
700 | 1 | _aTabberer, Maggie | |
700 | 1 | _aZhu, Chang-Qing | |
700 | 1 | _aPascoe, Steven J | |
773 | 0 |
_tAmerican journal of respiratory and critical care medicine _gvol. 197 _gno. 4 _gp. 542-543 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1164/rccm.201709-1831LE _zAvailable from publisher's website |
999 |
_c27604176 _d27604176 |